Skip to main content
logo
10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
56.09
-2.06 (-3.54%)
At close: Aug 14, 2026, 4:00 PM EDT
56.25
+0.16 (0.29%)
Pre-market: Aug 17, 2026, 8:27 AM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Single Cell Instruments Revenue
19.34M22.67M35.21M
Spatial Instruments Revenue
27.05M34.11M57.50M
Total Instruments Revenue
46.39M56.78M92.72M
Single Cell Consumables Revenue
370.65M363.21M372.31M
Spatial Consumables Revenue
159.54M143.98M121.12M
Total Consumables Revenue
530.19M507.18M493.43M
Services Revenue
36.11M32.73M24.32M
License and Royalty Revenue
4.21M46.14M321.00K
Revenue (Total)
616.91M642.82M610.79M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
United States Revenue
315.01M346.51M334.32M
North America (ex-United States) Revenue
12.17M12.26M13.45M
Europe, Middle East and Africa Revenue
171.91M161.72M159.76M
China Revenue
61.02M70.26M57.30M
Asia-Pacific (ex-China) Revenue
56.81M52.07M45.96M
Revenue (Total)
616.91M642.82M610.79M

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Cumulative Instruments Sold
8.05K7.04K
Total Consumables Reactions Sold
424.00K357.10K